Kaushiki Mazumdar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kaushiki Mazumdar has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Noton Kumar Dutta
Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
27 shared publications Sujata G. Dastidar
9 shared publicationsSujata G Dastidar
6 shared publicationsKumkum Ganguly
4 shared publicationsNoboru Motohashi
4 shared publications- Sujata G. Dastidar
Department of Microbiology, Herbicure Healthcare Bio-Herbal Research Foundation, Kolkata 700154, India
4 shared publications
Latest Publications
- 22 July 2020
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (8)
Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste
A life-threatening, emerging respiratory disease called Coronavirus Disease 2019 (COVID-19) 26 originated in the city of Wuhan in China9s Hubei province in December, 2019 and has been classified as 27 an international pandemic by the World Health Organization.…
- 22 July 2020
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (8)
Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste
A life-threatening, emerging respiratory disease called Coronavirus Disease 2019 (COVID-19) 26 originated in the city of Wuhan in China9s Hubei province in December, 2019 and has been classified as 27 an international pandemic by the World Health Organization.…
- Open Access
- 16 June 2020
- Published by American Society for Microbiology in Journal of Virology
- Vol. 94 (13)
The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- 16 June 2020
- Published by American Society for Microbiology in Journal of Virology
- Vol. 94 (13)
Open AccessThe Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- Open Access
- 10 January 2014
- Published by Sciencedomain International in British Journal of Medicine and Medical Research
- Vol. 4 (27) , 4533-4541
Evaluation of Pathogenic Potentialities and Transmissibility of Aerobic and Anaerobic Bacteria in Sexually Transmitted Diseases
Aims: Sexually transmitted diseases (STDs) caused by various aerobic and anaerobic bacteria have been reported from many developed and developing countries of the world. However, there is limited data available on the association of these pathogens with STDs on the Indian sub-continent. Therefore, the aim of this is to the presence of anaerobic and aerobic bacteria in sexually transmitted infections. Study Design: Patients attending the Department of Dermatology, Venereology & Leprology, Calcutta Medical College & Hospital, suspected to be suffering from STDs, were thoroughly examined and those having typical lesions of chancroid were excluded from further work. The prevalence of different aerobic and anaerobic bacteria was determined from among the remaining patients after ruling out cases of chancres. Place and Duration of Study: This work was carried out in the Department of Oral Medicine, R. Ahmed Dental College; Department of Dermatalogy, Venereology & Leprology, Calcutta Medical College and Hospital; Division of Microbiology, Department of Pharmaceutical Technology, Jadavpur University and Department of Microbiology, Herbicure Healthcare Bio-Herbal Research Foundation, Kolkata, for a period of seven months from April 1 to October 31, 2012. Methodology: At least two smears were prepared from the infected ulcers of each of the patients who were not diagnosed as of chancroid. One smear was for dark ground microscopy and the other for Gram’s staining. Confirmation of chancre was by serological testing, while aerobes/anaerobes were identified following standard procedures. Results: The organisms isolated were Staphylococcus aureus, Shigella flexneri, Shigella sonnei, Gardenerella vaginalis, Actinomyces spp, Veillonella purvula, Peptococcus heliotrinreducens, Peptostreptococcus magnus and Peptostreptococcus hydrogenalis. These were subjected to tests for their antibiotic sensitivity pattern which was followed by successful specific therapy. Conclusion: Various Gram positive and Gram negative aerobes and anaerobes were found to be associated with STDs and these were transmissible among homosexual and heterosexual partners.
- 10 January 2014
- Published by Sciencedomain International in British Journal of Medicine and Medical Research
- Vol. 4 (27) , 4533-4541
Open AccessEvaluation of Pathogenic Potentialities and Transmissibility of Aerobic and Anaerobic Bacteria in Sexually Transmitted Diseases
Aims: Sexually transmitted diseases (STDs) caused by various aerobic and anaerobic bacteria have been reported from many developed and developing countries of the world. However, there is limited data available on the association of these pathogens with STDs on the Indian sub-continent. Therefore, the aim of this is to the presence of anaerobic and aerobic bacteria in sexually transmitted infections. Study Design: Patients attending the Department of Dermatology, Venereology & Leprology, Calcutta Medical College & Hospital, suspected to be suffering from STDs, were thoroughly examined and those having typical lesions of chancroid were excluded from further work. The prevalence of different aerobic and anaerobic bacteria was determined from among the remaining patients after ruling out cases of chancres. Place and Duration of Study: This work was carried out in the Department of Oral Medicine, R. Ahmed Dental College; Department of Dermatalogy, Venereology & Leprology, Calcutta Medical College and Hospital; Division of Microbiology, Department of Pharmaceutical Technology, Jadavpur University and Department of Microbiology, Herbicure Healthcare Bio-Herbal Research Foundation, Kolkata, for a period of seven months from April 1 to October 31, 2012. Methodology: At least two smears were prepared from the infected ulcers of each of the patients who were not diagnosed as of chancroid. One smear was for dark ground microscopy and the other for Gram’s staining. Confirmation of chancre was by serological testing, while aerobes/anaerobes were identified following standard procedures. Results: The organisms isolated were Staphylococcus aureus, Shigella flexneri, Shigella sonnei, Gardenerella vaginalis, Actinomyces spp, Veillonella purvula, Peptococcus heliotrinreducens, Peptostreptococcus magnus and Peptostreptococcus hydrogenalis. These were subjected to tests for their antibiotic sensitivity pattern which was followed by successful specific therapy. Conclusion: Various Gram positive and Gram negative aerobes and anaerobes were found to be associated with STDs and these were transmissible among homosexual and heterosexual partners.
- 15 December 2011
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 58,p. e3154
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Tissue transglutaminase 2 (tTG2) is an intestinal digestive enzyme which deamidates already partially digested dietary gluten e.g. gliadin peptides. In genetically predisposed individuals, tTG2 triggers autoimmune responses that are characterized by the production of tTG2 antibodies and their direct deposition into small intestinal wall 1,2. The presence of such antibodies constitutes one of the major hallmarks of the celiac disease (CD). Epidermal transglutaminase (eTG) is another member of the transglutaminase family that can also function as an autoantigen in a small minority of CD patients. In these relatively rare cases, eTG triggers an autoimmune reaction (a skin rash) clinically known as dermatitis herpetiformis (DH). Although the exact mechanism of CD and DH pathogenesis is not well understood, it is known that tTG2 and eTG share antigenic epitopes that can be recognized by serum antibodies from both CD and DH patients 3,4. In this study, the confocal microscopy examination of biopsy samples from skin lesions of two rhesus macaques (Macaca mulatta) with dermatitis (Table 1, Fig. 1 and 2) was used to study the affected tissues. In one animal (EM96) a spectral overlap of IgA and tTG2 antibodies (Fig. 3) was demonstrated. The presence of double-positive tTG2+IgA+ cells was focused in the deep epidermis, around the dermal papillae. This is consistent with lesions described in DH patients 3. When EM96 was placed on a gluten-free diet, the dermatitis, as well as tTG2+IgA+ deposits disappeared and were no longer detectable (Figs. 1-3). Dermatitis reappeared however, based on re-introduction of dietary gluten in EM96 (not shown). In other macaques including animal with unrelated dermatitis, the tTG2+IgA+ deposits were not detected. Gluten-free diet-dependent remission of dermatitis in EM96 together with presence of tTG2+IgA+ cells in its skin suggest an autoimmune, DH-like mechanism for the development of this condition. This is the first report of DH-like dermatitis in any non-human primate.
- 15 December 2011
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 58,p. e3154
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Tissue transglutaminase 2 (tTG2) is an intestinal digestive enzyme which deamidates already partially digested dietary gluten e.g. gliadin peptides. In genetically predisposed individuals, tTG2 triggers autoimmune responses that are characterized by the production of tTG2 antibodies and their direct deposition into small intestinal wall 1,2. The presence of such antibodies constitutes one of the major hallmarks of the celiac disease (CD). Epidermal transglutaminase (eTG) is another member of the transglutaminase family that can also function as an autoantigen in a small minority of CD patients. In these relatively rare cases, eTG triggers an autoimmune reaction (a skin rash) clinically known as dermatitis herpetiformis (DH). Although the exact mechanism of CD and DH pathogenesis is not well understood, it is known that tTG2 and eTG share antigenic epitopes that can be recognized by serum antibodies from both CD and DH patients 3,4. In this study, the confocal microscopy examination of biopsy samples from skin lesions of two rhesus macaques (Macaca mulatta) with dermatitis (Table 1, Fig. 1 and 2) was used to study the affected tissues. In one animal (EM96) a spectral overlap of IgA and tTG2 antibodies (Fig. 3) was demonstrated. The presence of double-positive tTG2+IgA+ cells was focused in the deep epidermis, around the dermal papillae. This is consistent with lesions described in DH patients 3. When EM96 was placed on a gluten-free diet, the dermatitis, as well as tTG2+IgA+ deposits disappeared and were no longer detectable (Figs. 1-3). Dermatitis reappeared however, based on re-introduction of dietary gluten in EM96 (not shown). In other macaques including animal with unrelated dermatitis, the tTG2+IgA+ deposits were not detected. Gluten-free diet-dependent remission of dermatitis in EM96 together with presence of tTG2+IgA+ cells in its skin suggest an autoimmune, DH-like mechanism for the development of this condition. This is the first report of DH-like dermatitis in any non-human primate.
- 1 May 2011
- Published by Bentham Science Publishers Ltd. in Recent Patents on Anti-Infective Drug Discovery
- Vol. 6 (2) , 128-138
New Patentable Use of an Old Neuroleptic Compound Thioridazine to Combat Tuberculosis: A Gene Regulation Perspective
Use of the old antipsychotic phenothiazine thioridazine (THZ) for therapy of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) infection is now being seriously considered. It is reported that THZ primarily acts on enzymes involved in fatty acid metabolism and membrane proteins, particularly efflux pumps, as well as oxidoreductases and proteins involved in aerobic respiration that overlap with a number of conventional antituberculous drugs. It targets the products of the Rv3160c-Rv3161c operon, which are perhaps required for the detoxification of THZ, members of the sigma factor SigB regulon that play a crucial role in protecting the pathogen against cell envelope damage, and Rv2745c, a transcription factor that regulates ATP-dependent proteolysis. Some of these genes have been shown to be essential for the survival or persistence of Mycobacterium tuberculosis in the infected host. Since THZ targets multiple pathways, including those involved in cell wall processes and respiratory chain components, it may serve as a model for multi-target drug development, as well as constitute a highly potent addition to a combination of antituberculous drug regimens. The discussion of some of the patents relevant to thioridazine to combat tuberculosis is also included in the present manuscript.
- 1 May 2011
- Published by Bentham Science Publishers Ltd. in Recent Patents on Anti-Infective Drug Discovery
- Vol. 6 (2) , 128-138
New Patentable Use of an Old Neuroleptic Compound Thioridazine to Combat Tuberculosis: A Gene Regulation Perspective
Use of the old antipsychotic phenothiazine thioridazine (THZ) for therapy of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) infection is now being seriously considered. It is reported that THZ primarily acts on enzymes involved in fatty acid metabolism and membrane proteins, particularly efflux pumps, as well as oxidoreductases and proteins involved in aerobic respiration that overlap with a number of conventional antituberculous drugs. It targets the products of the Rv3160c-Rv3161c operon, which are perhaps required for the detoxification of THZ, members of the sigma factor SigB regulon that play a crucial role in protecting the pathogen against cell envelope damage, and Rv2745c, a transcription factor that regulates ATP-dependent proteolysis. Some of these genes have been shown to be essential for the survival or persistence of Mycobacterium tuberculosis in the infected host. Since THZ targets multiple pathways, including those involved in cell wall processes and respiratory chain components, it may serve as a model for multi-target drug development, as well as constitute a highly potent addition to a combination of antituberculous drug regimens. The discussion of some of the patents relevant to thioridazine to combat tuberculosis is also included in the present manuscript.
- 1 October 2010
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 36 (4) , 295-302
Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future
- 1 October 2010
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 36 (4) , 295-302
Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: scope and hope for the future
- Open Access
- 19 April 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (4) , e10228
Visualization of Transepithelial Passage of the Immunogenic 33-Residue Peptide from α-2 Gliadin in Gluten-Sensitive Macaques
Based on clinical, histopathological and serological similarities to human celiac disease (CD), we recently established the rhesus macaque model of gluten sensitivity. In this study, we further characterized this condition based on presence of anti-tissue transglutaminase 2 (TG2) antibodies, increased intestinal permeability and transepithelial transport of a proteolytically resistant, immunotoxic, 33-residue peptide from α2-gliadin in the distal duodenum of gluten-sensitive macaques. Six rhesus macaques were selected for study from a pool of 500, including two healthy controls and four gluten-sensitive animals with elevated anti-gliadin or anti-TG2 antibodies as well as history of non-infectious chronic diarrhea. Pediatric endoscope-guided pinch biopsies were collected from each animal's distal duodenum following administration of a gluten-containing diet (GD) and again after remission by gluten-free diet (GFD). Control biopsies always showed normal villous architecture, whereas gluten-sensitive animals on GD exhibited histopathology ranging from mild lymphocytic infiltration to villous atrophy, typical of human CD. Immunofluorescent microscopic analysis of biopsies revealed IgG+ and IgA+ plasma-like cells producing antibodies that colocalized with TG2 in gluten-sensitive macaques only. Following instillation in vivo, the Cy-3-labeled 33-residue gluten peptide colocalized with the brush border protein villin in all animals. In a substantially enteropathic macaque with “leaky” duodenum, the peptide penetrated beneath the epithelium into the lamina propria. The rhesus macaque model of gluten sensitivity not only resembles the histopathology of CD but it also may provide a model for studying intestinal permeability in states of epithelial integrity and disrepair.
- 19 April 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (4) , e10228
Open AccessVisualization of Transepithelial Passage of the Immunogenic 33-Residue Peptide from α-2 Gliadin in Gluten-Sensitive Macaques
Based on clinical, histopathological and serological similarities to human celiac disease (CD), we recently established the rhesus macaque model of gluten sensitivity. In this study, we further characterized this condition based on presence of anti-tissue transglutaminase 2 (TG2) antibodies, increased intestinal permeability and transepithelial transport of a proteolytically resistant, immunotoxic, 33-residue peptide from α2-gliadin in the distal duodenum of gluten-sensitive macaques. Six rhesus macaques were selected for study from a pool of 500, including two healthy controls and four gluten-sensitive animals with elevated anti-gliadin or anti-TG2 antibodies as well as history of non-infectious chronic diarrhea. Pediatric endoscope-guided pinch biopsies were collected from each animal's distal duodenum following administration of a gluten-containing diet (GD) and again after remission by gluten-free diet (GFD). Control biopsies always showed normal villous architecture, whereas gluten-sensitive animals on GD exhibited histopathology ranging from mild lymphocytic infiltration to villous atrophy, typical of human CD. Immunofluorescent microscopic analysis of biopsies revealed IgG+ and IgA+ plasma-like cells producing antibodies that colocalized with TG2 in gluten-sensitive macaques only. Following instillation in vivo, the Cy-3-labeled 33-residue gluten peptide colocalized with the brush border protein villin in all animals. In a substantially enteropathic macaque with “leaky” duodenum, the peptide penetrated beneath the epithelium into the lamina propria. The rhesus macaque model of gluten sensitivity not only resembles the histopathology of CD but it also may provide a model for studying intestinal permeability in states of epithelial integrity and disrepair.
- 31 December 2009
- Published by Elsevier in Cellular Immunology
- Vol. 259 (1) , 33-40
TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation
- 31 December 2009
- Published by Elsevier in Cellular Immunology
- Vol. 259 (1) , 33-40
TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation
- 13 December 2009
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 29 (2) , 239-243
Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipine
The cardiovascular drug lacidipine (Lc) is known to possess antibacterial activity. Further potentiation of action is possible by synergism between Lc and an antibiotic or a non-antibiotic. The minimum inhibitory concentration (MIC) of antibiotics, Lc and other non-antibiotics were detected by the agar dilution technique in different bacteria. Synergism was determined by disc diffusion assay, the fractional inhibitory concentration (FIC) index through checkerboard assessment and, also, the protective capacity of the combination by administering the drugs along with 50 × LD50 challenge dose of virulent Salmonella typhimurium in animal experiments. Synergism between Lc and penicillin was found to be statistically significant (P ≤ 0.01) when compared with their individual effects. The FIC index of this combination was 0.375, confirming synergism. In vivo tests suggested the statistically significant protection of infected mice with this combination. Lc exhibited synergism when combined with non-antibiotics methdilazine and triflupromazine both in vitro and in vivo. Distinct antimicrobial action of Lc and its subsequent synergism with other drugs can open up the possibility of synthesising new molecules by the structural analyses of these compounds.
- 13 December 2009
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 29 (2) , 239-243
Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipine
The cardiovascular drug lacidipine (Lc) is known to possess antibacterial activity. Further potentiation of action is possible by synergism between Lc and an antibiotic or a non-antibiotic. The minimum inhibitory concentration (MIC) of antibiotics, Lc and other non-antibiotics were detected by the agar dilution technique in different bacteria. Synergism was determined by disc diffusion assay, the fractional inhibitory concentration (FIC) index through checkerboard assessment and, also, the protective capacity of the combination by administering the drugs along with 50 × LD50 challenge dose of virulent Salmonella typhimurium in animal experiments. Synergism between Lc and penicillin was found to be statistically significant (P ≤ 0.01) when compared with their individual effects. The FIC index of this combination was 0.375, confirming synergism. In vivo tests suggested the statistically significant protection of infected mice with this combination. Lc exhibited synergism when combined with non-antibiotics methdilazine and triflupromazine both in vitro and in vivo. Distinct antimicrobial action of Lc and its subsequent synergism with other drugs can open up the possibility of synthesising new molecules by the structural analyses of these compounds.
- 1 December 2009
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 58 (12) , 1667-1668
Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice
- 1 December 2009
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 58 (12) , 1667-1668
Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice